SNT
SYNTARA LIMITED
$0.0250
0.00%
Market cap
$49M
Turnover
$148,891
Last price
$0.0250
Day change
0.00%
Announcements
18
Range, past year
Open 0.034 · Low 0.019 · Now 0.025 · High 0.083
Open SNT in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
SNT momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-10-13.
Momentum quality
32/100
Wyckoff phase
Accumulation4d
Trend stage
Emerging
1 Day
+0.0%
1 Week
+25.0%
1 Month
+4.2%
1 Year
-24.2%
RSI
56
Avg daily range
7.7%
SYNTARA LIMITED scores 32 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Emerging.
On the Wyckoff cycle it sits in Accumulation, where it has been for 4 trading days. The weekly timeframe reads Downtrend, which does not yet agree with the daily view.
Against the wider market it is currently outperforming and the institutional accumulation signal reads low.
What stands out
- RSI in healthy zone (56)
Points to watch
- 60d drawdown -42.9%
- High volatility (ATR 7.7%)
- Risk rating: Very High
- Composite downside risk elevated
SNT announcements
Recent price-sensitive releases.
- 2026-10-07 Further significant results from SNT-4728 iRBD Phase 2 trial Progress Report
- 2026-10-01 Syntara expands SNT-9465 skin scarring study Progress Report
- 2026-08-27 Appendix 4E and Annual Report Annual Report | Top 20 shareholders | Preliminary Final Report | Full Year Accounts | Full Year Audit Review | Full Year Directors' Statement | Full Year Directors' Report
- 2026-07-27 Quarterly Activities/Appendix 4C Cash Flow Report Commitments Test Entity - Fourth Quarter Activity Report | Commitments Test Entity - Fourth Quarter Cashflow Report
- 2026-07-06 Encouraging SNT-4728 Phase 2 iRBD results
- 2026-07-03 Trading Halt
- 2026-06-10 Results of Share Purchase Plan
More Health Care stocks
Most traded in the same sector.